FRONTEO joins Oita University and Beppu City’s AMED dementia research and development project
Summary
FRONTEO is joining an AMED dementia research program led by Oita University and Beppu City. The company will use its KIBIT AI to help develop and evaluate an early detection model for Alzheimer’s disease. The study will run as a prospective cohort trial in Beppu with 800 residents aged 50 to under 90. The initiative also aims to support future deployment in municipal health checks and primary care, improving diagnosis support and efficiency.
Classifications
industries
HealthTech
applications
Business Intelligence
AskAI Classifications
Labels
SaaS
Artificial Intelligence Software
Legal Tech Software
Linked Companies
Fronteo
$100M to $250M